- Home
- NEO vs DX Comparison
NEO vs DX Comparison
Compare NEO & DX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEO
- DX
- Stock Information
- Founded
- NEO 2001
- DX 1987
- Country
- NEO United States
- DX United States
- Employees
- NEO N/A
- DX N/A
- Industry
- NEO Precision Instruments
- DX Real Estate Investment Trusts
- Sector
- NEO Health Care
- DX Real Estate
- Exchange
- NEO Nasdaq
- DX Nasdaq
- Market Cap
- NEO 1.2B
- DX 1.1B
- IPO Year
- NEO 1999
- DX N/A
- Fundamental
- Price
- NEO $9.55
- DX $11.67
- Analyst Decision
- NEO Strong Buy
- DX Buy
- Analyst Count
- NEO 10
- DX 5
- Target Price
- NEO $19.44
- DX $12.88
- AVG Volume (30 Days)
- NEO 1.9M
- DX 5.0M
- Earning Date
- NEO 04-29-2025
- DX 04-21-2025
- Dividend Yield
- NEO N/A
- DX 15.85%
- EPS Growth
- NEO N/A
- DX N/A
- EPS
- NEO N/A
- DX 1.49
- Revenue
- NEO $660,566,000.00
- DX $150,396,000.00
- Revenue This Year
- NEO $13.06
- DX N/A
- Revenue Next Year
- NEO $11.18
- DX $13.26
- P/E Ratio
- NEO N/A
- DX $7.83
- Revenue Growth
- NEO 11.65
- DX 462.25
- 52 Week Low
- NEO $8.05
- DX $10.79
- 52 Week High
- NEO $19.11
- DX $14.52
- Technical
- Relative Strength Index (RSI)
- NEO 48.48
- DX 34.64
- Support Level
- NEO $8.05
- DX $11.58
- Resistance Level
- NEO $10.18
- DX $11.91
- Average True Range (ATR)
- NEO 0.72
- DX 0.52
- MACD
- NEO 0.16
- DX -0.06
- Stochastic Oscillator
- NEO 70.42
- DX 36.67
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
About DX Dynex Capital Inc.
Dynex Capital Inc is an internally managed mortgage real estate investment trust, which invests in mortgage-backed securities. The company invests in residential and commercial mortgage-backed securities. Its objective is to provide attractive risk-adjusted returns to shareholders over the long term that are reflective of a leveraged, high quality fixed income portfolio with a focus on capital preservation. Its investments consist principally of Agency mortgage-backed securities including residential MBS and commercial MBS.